¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chromosome chain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • reverse transcriptase polymerase chain reaction
    ¿ªÀü»çÈ¿¼ÒÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ
  • sympathetic chain
    ±³°¨½Å°æÁÙ±â
  • side chain
    °ç»ç½½
  • side chain isomerism
    ¿·»ç½½À̼º
  • accessory chromosome
    µ¡¿°»öü
  • acentric chromosome
    ¹«Áß½ÉÀý¿°»öü
  • autosomal chromosome
    º¸Åë¿°»öü, »ó¿°»öü
  • acrocentric chromosome
    ³¡°ç¸Åµì¿°»öü
  • bacterial artificial chromosome
    ¹ÚÅ׸®¾Æ¼ºÀΰø¿°»öü
  • bivalent chromosome
    À̰¡¿°»öü
  • circular chromosome
    °í¸®¿°»öü
  • chromosome
    ¿°»öü
  • chromosome association
    ¿°»öüÁ¢ÇÕ
  • chromosome band
    ¿°»öü¶ì
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • accessory chromosome
    (¢¡supernumerary chromosome) °úÀ׿°»öü
  • acentric chromosome
    ¹«Áß½ÉÀý¿°»öü
  • acrocentric chromosome
    ³¡°ç¸Åµì¿°»öü
  • autosomal chromosome
    º¸Åë¿°»öü
  • chromosome abnormality
    ¿°»öüÀÌ»ó
  • chromosome association
    ¿°»öüÁ¢ÇÕ
  • bivalent chromosome
    µÎ¹è¼ö¿°»öü
  • chromosome band
    ¿°»öü¶ì
  • chromosome breakage
    ¿°»öü¼Õ»ó
  • chromosome bridge
    ¿°»öü´Ù¸®, ¿°»öü±³
  • chromosome
    ¿°»öü
  • chromosome configuration
    ¿°»öüÁ¢ÇÕÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • heavy chain
    Áß¼â
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain disease
    H¼âº´(¡­áðÜ»), Á߼⺴(ñìáðÜ»).
  • heavy chain disease
    Áß ¼âº´
  • heavy-chain disease
    Á߼⺴
  • hemoglobin a,b-globin chain of
    ¥â-±Û·Îºó¼â(¡­áð)
  • hemolytic chain
    ¿ëÇ÷¿¬¼â.
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain, kappa (¥ê)
    Ä«ÆÄ»ç½½, Ä«ÆÄ¼â
  • chain, lambda (¥ë)
    ¶÷´Ù»ç½½, ¶÷´Ù¼â
  • chain, light
    °æ¼â, °æ»ç½½, L¼â
  • chain, mu (¥ì)
    ¹Â»ç½½, ¹Â¼â
  • delta (¥ä) chain
    ÅÚŸ»ç½½, µ¨Å¸¼â
  • epsilon (¥å) chain
    ¿¦½Ç·Ð»ç½½, ¿¦½Ç·Ð¼â
  • food chain =biological concentration
    ½Äǰ¿¬¼â(¡­ææáð).
  • gamma (¥ã) chain
    °¨¸¶»ç½½, °¨¸¶¼â
  • gamma heavy chain disease
    °¨¸¶Á߼⺴(¡­ñìáðÜ»).
  • gamma heavy chain disease
    °¨¸¶Á߼⺴
  • gamma heavy chain disease
    °¨¸¶Á߼⺴(¡­ñìáðÜ»).
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • heavy chain
    Áß¼â
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • chain initiation
    »ç½½Çü¼º(û¡à÷)°³½Ã(ËÒã·)
  • chain isomer
    »ç½½À̼ºÃ¼(ì¶àõô÷)
  • chain length
    »ç½½ ±æÀÌ
  • chain propagation
    »ç½½ Áõ½Ä(ñòãÖ)
  • chain reaction
    ¿¬¼â¹ÝÀÀ(ææáðÚãëë)
  • chain termination
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ)
  • chain termination codon
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) ÄÚµç
  • chain termination mutation
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) º¯ÀÌ(ܨì¶)
  • chain terminator
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ(ðûÖõí­)
  • chain terminator method
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ¹ý(ðûÖõí­Ûö)
  • closed chain
    "´ÝÈù »ç½½, Æó¼â(øÍáð) (ÔÒ) ring"
  • decay chain
    "ºØ±«(ÝÚÎÕ) »ç½½, (ÔÒ) radioactive series"
  • delta chain
    µ¨Å¸ »ç½½
  • DNA polymerase chain reaction
    DNA Æú¸®¸Ó·¹À̽º ¿¬¼â ¹ÝÀÀ(ææáðÚãëë) (ÔÒ) polymerase chain reaction
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CHC chromosome condensation; community health center; community health computing; community health counc...
chr chromosome; chronic
CMGT chromosome-mediated gene transfer
CMS children's medical services; Christian Medical Society; chronic myelodysplastic syndrome; chromosome...
cs chromosome; consciousness
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MCM Mini-chromosome maintenance
PAC P-1 artificial chromosome
PAC Pl-derived artificial chromosome
Ph1 Philadelphia Chromosome
PH Philadelphia chromosome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chromosome painting
    ¿°»öü ÆäÀÎÆÃ, ¿°»öü Âø»ö
  • chromosome recombination
    ¿°»öü Àç°áÇÕ
  • chromosome-breakage syndrome
    ¿°»öü-ºÐÇØ ÁõÈıº
  • circular chromosome
    ȯ»ó ¿°»öü
  • extra chromosome
    °úÀ× ¿°»öü
    »ý¹° Á¾¿¡ À־ Á¤»óÀûÀÎ ¿°»öü ±¸¼º¿øÀÌ ¾Æ´Ñ ¿°»öü. Áï, »ý¹°Àº Á¾¸¶´Ù ÀÏÁ¤ÇÑ ¿°»öü ¼ö·Î ÇÑ Á¶¸¦ ÀÌ·é´Ù. ÀÌ ¿°»öü Á¶ÀÇ Á¤»óÀûÀÎ ±¸¼º¿ø
  • homologous chromosome
    »óµ¿ ¿°»öü
    ÇüÅÂ¿Í ÇÔÀ¯Çϰí ÀÖ´Â À¯ÀüÀÚ°¡ ½ÖÀÌ µÉ ¼ö ÀÖ´Â 1½ÖÀÇ ¿°»öü. º¸Åë »ý¹°Àº 2¹è¼ºÀ̸ç 2Á¶ÀÇ ¿°»öü¸¦ °¡Áö°í ÀÖÀ¸¹Ç·Î °¢ ¿°»öü´Â ½ÖÀÌ µÉ ¼ö ÀÖ´Ù. »óµ¿ ¿°»öü´Â ÇÙ ºÐ¿­À» ÇÒ ¶§ ¹Ýµå½Ã ÀÎÁ¢ÇÏ¿© Á¸ÀçÇÏ´Â °ÍÀº ¾Æ´ÏÁö¸¸, °¨¼öºÐ¿­ÀÇ Á߱⿡´Â Á¢ÇÕÇÏ¿© »óÁ¢Çϸç, Èı⿡´Â ºÐ¸®ÇÏ¿© ¹Ý´ëÀÇ ±ØÀ¸·Î ³ª´©¾îÁø´Ù. ¶§·Î´Â »óµ¿ ¿°»öü°¡ ºÎµîÇüÀ» ÀÌ·ç´Â °æ¿ì°¡ Àִµ¥, X ¿°»öü³ª Y ¿°»öü µîÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
  • lampbrush chromosome
    ·¥ÇÁ ºê·¯½Ã ¿°»öü
    ôÃß, ¹«Ã´Ãßµ¿¹°ÀÇ °¨¼öºÐ¿­ Àü±âÀÇ µðÇ÷ÎÅٱ⿡¼­ ³­¸ð¼¼Æ÷ ÇÙÀÇ °Å´ëÇÑ 2°¡ ¿°»öü ¹× ³ë¶û ÃÊÆÄ¸®·ùÀÇ Á¤¸ð¼¼Æ÷ ÇÙ ³»ÀÇ Y ¿°»öü¿¡¼­ °üÂûµÇ´Â ¿°»öü. ÁÖÃà¿¡ µû¶ó ¸¹Àº ¼öÀÇ ·çÇÁ ¸ð¾çÀÇ µ¹Ãâ¹°ÀÌ ¿·¿¡¼­ ³ª¿Í ÀÖ¾î ¿°»öü Àüü°¡ ¾óÇÍ º¸¾Æ ·¥ÇÁ¸¦ ´Û´Â ºê·¯½Ã¿Í °°ÀÌ »ý°å´Ù°í ÇØ¼­ ÀÌ·± À̸§ÀÌ ºÙ¿©Á³´Ù. ¿°»öºÐüÀÇ »óµ¿ ºÎºÐÀÌ ¼­·Î ¸Â´ë°í ÀÖ°í, DNA¿Í ´Ü¹éÁú·Î ±¸¼ºµÇ´Â ºñÈÄÇÑ ÀÔÀÚ ¸ð¾çÀÇ ÁÖÃà ºÎºÐ°ú, °Å±â¿¡¼­ ÇÑ ½Ö¾¿ ¿·À¸·Î ³­ DNA ¼¶À¯¿Í ¸®º¸ ÇÙ ´Ü¹éÁú·Î ÀÌ·ç¾îÁø ·çÇÁ ±¸Á¶ ºÎºÐÀ¸·Î µÇ¾î ÀÖ´Ù. ¿µ¿ø
  • mapping chromosome
    ÁöµµÈ­ ¿°»öü
    ¼­·Î ¿¬¼âµÇ¾î ÀÖ´Â À¯ÀüÀÚÀÇ °¢°¢ÀÇ À§Ä¡¸¦ ¿°»öü À§ÀÇ »ó´ëÀûÀÎ ¼ø¼­³ª °Å¸®¿¡ µû¶ó¼­ ÇÑ °¡´ÚÀÇ Á÷¼± À§¿¡ µµ½ÄÀûÀ¸·Î ±×·ÁÁø ¿°»öü.
  • matrix of chromosome
    ¿°»öü ¹ÙÅÁÁú
  • meiotic chromosome
    °¨¼ö ºÐ¿­ ¿°»öü, ¿°»öü ³ª¼±
  • metacentric chromosome
    Áß¾Ó µ¿¿øÃ¼, Áß¾Ó Áß½ÉÀý ¿°»öü
  • monocentric chromosome
    Ȭ Áß½ÉÀý ¿°»öü
  • morphological aberration of chromosome
    ¿°»öü ÇüÅ ÀÌ»ó
  • quadrivalent chromosome
    ³×¹è¼ö ¿°»öü
  • rearrangement chromosome
    Àç¹è¿­ ¿°»öü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
chromosome 9 Trisomy 9 can be homogenous or mosaic. Microcephaly with dolichocephaly, enophthalmy and microretrognathia are present. Characteristic osteoarticular anomalies include dislocation of the hips, knees or elbows, deformities of the spinal cord and rib anomalies. Inner organ malformations involve cardiac, cerebral, renal and occasionally digestive anomalies. The prognosis is most severe.
The 9p monosomy syndrome is characterised by trigonocephaly, long upper lip with undefined philtral borders, short nose, anteverted nares, psychomotor retardation, upward slant of palpebral fissures, dolichomesophalangy. Malformations are severe. The majority of the cases occur de novo, or can result from a parental translocation. 9p trisomy was the first partial trisomy identified before the use of banding techniques and is probably one of the most frequently detected. The majority of pure 9p trisomies occur de novo. In 9q trisomy and associated 9p trisomy, malsegregation of a parental rearrangement is always involved. Craniofacial dysmorphism includes brachycephaly, bulbous nose and short upper lip with a very characteristic asymmetric grin when the mouth opens. The knit brows, slanted palpebral fissures and mouth give a particularly distinctive worried look. The palms are long in comparison with the fingers. A single palmar crease is constant. Malformations are rare in cases of pure 9p trisomy but they are numerous and diverse in cases of associated 9p trisomy. Mental retardation is variable. Life expectancy is not impaired.
Tetrasomy 9p is remarkable due to the infrequency of autosomal tetrasomies. The phenotype is variable and the facial dysmorphism can resemble that of 9p trisomy. Malformations are severe and numerous. Homogeneous tetrasomies lead to early death. Mosaicism appears to diminish the severity of the outlook.
9q32 trisomy shows dolichocephaly, deep set eyes with short palpebral fissures, large poorly folded ears, beaked nose, marked microretrognathia, long abnormally implanted fingers and toes and severe developmental delay. Inner organ malformations involve the heart. The trisomy results from a tandem duplication arising de novo or from malsegregation of a parental rearrangement. Interstitial deletion 9q22-q32 is reported with multiple congenital anomalies.
The phenotype of ring chromosome 9 is variable and the principal features of 9p monosomy can be observed, as well as certain malformations seen in trisomy 9.
Some major genes on chromosome 9 are those for the ABO blood group, fibroblast and leukocyte interferons, familial dysautonomia, Friedreich ataxia, nail-patella syndrome and galactose-1-phosphate uridyltransferase, whose deficiency causes galactosaemia.
(05 Mar 2000)
chromosome aberration Any deviation from the normal number or morphology of chromosomes; also the phenotypic consequences thereof.
(05 Mar 2000)
chromosome aberrations Deviations from the normal number or structure of chromosomes, not necessarily associated with disease.
(12 Dec 1998)
chromosome abnormalities Defects in the structure or number of chromosomes resulting in structural aberrations or manifesting as disease.
(12 Dec 1998)
chromosome band A region of darker or contrasting staining across the width of a chromosome; the pattern of band's is characteristic for most chromosomes.
(05 Mar 2000)
chromosome banding Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping.
(12 Dec 1998)
chromosome breakage A type of chromosomal aberration which may result from spontaneous or induced breakage. Alkylating agents, various types of irradiation, and chemical mutagens have been found to cause induced chromosomal breakage. Breakage can induce base pair translocations, deletions, or chromatid breakage.
(12 Dec 1998)
chromosome complement The whole set of chromosomes for the species. In humans, the chromosome complement (which is also called the karyotype) consists of 46 chromosomes.
(12 Dec 1998)
chromosome condensation <cell biology> The tight packing of DNA into chromosomes in metaphase, in preparation for cell division.
(18 Nov 1997)
chromosome deletion Actual loss of a portion of the chromosome.
(12 Dec 1998)
chromosome disorder An abnormal condition due to an abnormality of the chromosomes. For example, Down syndrome (the genetic abnormality featuring three chromosome 21s, instead of two, also refered to as trisomy 21) is a chromosome disorder.
(12 Dec 1998)
chromosome fragile sites Heritable sensitive regions of chromosomes which show up in vitro as non-staining bands. They are associated with chromosome breakage and other aberrations, and, when located on sex chromosomes, they produce phenotypic abnormalities. No abnormal phenotype has been definitely identified with autosomal fragile sites, but some rare autosomal recessive disorders may be due to homozygosity for fragile sites. Fragile sites are designated by the letters "fra" followed by the designation for the specific chromosome and locus.
(12 Dec 1998)
chromosome map The chart of the linear array of genes on a chromosome. The Human Genome Project aims to map all of the human chromosomes.
(12 Dec 1998)
chromosome mapping The mapping of the relative locations of genes on a chromosome by analysing linkage frequencies (how often different genes are inherited together) and crossover frequencies (how often different combinations of three or more genes are inherited) or recombination frequencies.
(09 Oct 1997)
chromosome mosaicism See: mosaic.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain reaction
    ¿¬¼â ¹ÝÀÀ;(»ç°Ç µîÀÇ)¿¬¼â ¹ÝÀÀ
  • chain reactor
    ¿¬¼â ¹ÝÀÀ ÀåÄ¡;¿øÀÚ·Î
  • chain rule
    ¿¬¼â ¹ýÄ¢
  • chain saw
    ÈÞ´ë¿ë µ¿·Â »ç½½Åé;üÀμÒ
  • chain shot
    »ç½½Åº(ÇØÀü¿¡¼­ µÀ´ë µîÀ» ÆÄ±«Çϱâ À§ÇØ ¾´ ¼è»ç½½·Î ÀÌÀº µÎ°³ÀÇ ´ëÆ÷¾Ë)
  • chain smoker
    ÁÙ´ã¹è ÇÇ¿ì´Â »ç¶÷
  • chain stitch
    (...À») »ç½½ ¸ð¾çÀ¸·Î ¶ß´Ù
  • chain store
    üÀνºÅä¾î;¿¬¼âÁ¡
  • chain-react
    ¿¬¼â ¹ÝÀÀÀ» ÀÏÀ¸Å°´Ù
  • chain-reacting pile
    ¿¬¼â¹ÝÀÀ·Î;¿øÀÚ·Î
  • chain-smoke
    ÁÙ´ã¹è¸¦ ÇÇ¿ì´Ù;(´ã¹è¸¦) ÀÕ´Þ¾Æ ÇÇ¿ì´Ù
  • chain-wheel
    (ÀÚÀü°Å µîÀÇ) »ç½½ Åé´Ï¹ÙÄû
  • chain-work
    »ç½½ ¼¼°ø;»ç½½ ¹«´Ì
  • closed chain
    Æó¼â
  • cold chain
    Àú¿Â À¯Åë ü°è(»ý¼±.¾ßäµîÀ» ³ÃÀå,Àú¿Â »óÅ·Π°ø±ÞÇÔ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á